Skip to main content
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
20.23
+0.26 (1.30%)
At close: Dec 20, 2024, 4:00 PM
19.31
-0.92 (-4.55%)
After-hours: Dec 20, 2024, 4:03 PM EST

Embecta Revenue

In the fiscal year ending September 30, 2024, Embecta had annual revenue of $1.12B with 0.21% growth. Embecta had revenue of $286.10M in the quarter ending September 30, 2024, with 1.49% growth.

Revenue (ttm)
$1.12B
Revenue Growth
+0.21%
P/S Ratio
1.04
Revenue / Employee
$510,500
Employees
2,200
Market Cap
1.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20241.12B2.30M0.21%
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pediatrix Medical Group 2.01B
Progyny 1.14B
Myriad Genetics 823.60M
Tilray Brands 812.04M
Artivion 384.90M
Innoviva 352.75M
Ardelyx 251.85M
Weave Communications 195.84M
Revenue Rankings

EMBC News

More News